Curriculum Vitae
2024
Thomas H. Swanson, MD, FAES
Diplomate, American Board of Psychiatry and Neurology
Diplomate, American Board of Clinical Neurophysiology
Education:
2006-08 Cleveland Marshall School of Law
M.D. 1986 Wayne State University School of Medicine, Detroit, MI
1980-82 University of Houston, Houston, TX, Graduate School, Marine Biology
B.S. 1979 Eastern Michigan University, Ypsilanti, MI, Major Biology, Minor Psychology
1975-77 University of Houston, Houston, TX
Training:
1990-92 Post-Doctoral Research Fellowship, University of Pennsylvania, Philadelphia, PA,,laboratory of Marc Dichter, MD, PhD
1990-92 Clinical Epilepsy Fellowship, University of Pennsylvania Graduate Hospital Comprehensive Epilepsy Program, Philadelphia, PA
1987-90 Neurology Residency, Mayo Clinic, Rochester, MN
1986-87 Internal Medicine Internship, Henry Ford Hospital, Detroit, MI
Medical License and Board Certification:
Active
2018 Michigan
2008 Montana
1996 Board Certified, American Board of Clinical Neurophysiology
1996-2006 Board Certified, American Board of Psychiatry and Neurology, added qualifications in clinical neurophysiology
1992 Board Certified, American Board of Psychiatry and Neurology (Neurology)
Memberships and Services:
2024 Scientific Advisory Workgroup member, Michigan Cannabis Regulatory Agency
2023- Advisory Board member, Northwest VA Epilepsy Centers of Excellence which includes regional centers in Chicago, Madison, Minneapolis, Seattle, and Portland
2017-2020 Board of Directors, Winter Conference on Brain Research
2017-2019 Scientific Program Committee, Winter Conference on Brain Research,
2015- Chairman, Business Committee, Consortium of Private Epilepsy Centers,
2013-16 Scientific Program Committee, American Epilepsy Society,
2013-16 Advocacy Committee, American Epilepsy Society
2013-15 Corporate Affairs Committee, American Epilepsy Society
2013-14 Board of Directors, Idaho Epilepsy Foundation
2012,16 Neurology On The Hill participant, met with Idaho Senator Capo, lobbied for neuroscience research.
2011-1 4 Regional Work Group Member Institute of Translational Health Sciences, University of Washington Medical School
2010 Palatucci Fellow, American Academy of Neurology, Advocacy Research Fellowship learned how to drive advocacy using influence and process
2010-12 Team head injury physician, Arizona Diamondbacks organization minor league team the Missoula Osprey.
2010- Founding Board Member, Epilepsy Association of Montana
2010- Chairman, Professional Advisory Board, Epilepsy Association of Montana
2009-2012 St. Patrick Hospital / Community Medical Center joint Institutional Review Board
2009-2011 Scientific Program Committee, American Epilepsy Society
2009- UCB Pharmaceuticals, Professional Advisory Board and Speakers Board
2009-16 Speakers Board, Cyberonics (now Liva Nova)
2009-13 Professional Advisory and Speakers Board, Glaxo-Smith-Kline
2007-10 Facilities Chairman and Executive Committee member, Winter Conference on Brain Research
2006-09 Board Trustee, Epilepsy Association of Northeast Ohio
2002-04 Board of Directors member, Winter Conference on Brain Research
2002-05 Vestry member, Grace Episcopal Church, Sandusky, Ohio
2000-09 Professional Advisory Board, Michigan Chapter, Epilepsy Foundation of America
1996-1998 IRB committee member, Medical College of Ohio
1996-1998 IACUC (animal use) committee member, Medical College of Ohio
1994-1996 IRB committee member, Cleveland Clinic
1994-1996 IACUC (animal use) committee member, Cleveland Clinic
Member American Epilepsy Society
Past Member American Association for the Advancement of Science
Past Member American Medical Association
Past Member American Academy of Neurology
Past Member Society for Neuroscience
Past Member American Physiological Society
Doris A. Flynn Foundation Epilepsy Fellowship Selection Committee
Cleveland Clinic Research Program Committee
Ad Hoc Reviewer, VA Merit Review Board
Field Reviewer, Brain Research
Field Reviewer, J. Clinical Neurophysiology
Field Reviewer, Epilepsia
Field Reviewer, J. Neuroscience Methods
Field Reviewer, J. Neurosurgery
Academic and Professional Appointments:
2018-2019 Owner, Lucid Neurology Southfield, MI (sold 2019)
2017- CEO and Chief Science Officer, Sativa Science Inc.
2016 Fellow, American Epilepsy Society
2013-2018 CEO, Idaho Neurology
2011-2013 Board Partner Frontier Health Information Technology, Cody WY
2010-2013 Medical Director, Clinical Neurophysiology, Community Medical Center, Missoula, MT
2009- Faculty Affiliate, University of Montana, Center for Structural and Functional Neuroscience
2009- Medical Director, Montana Comprehensive Epilepsy Center
2009- CEO, Montana Neurology
2008-2009 Montana Neurobehavioral Associates
2004-2008 Research Associate, Department of Neuroscience, Oberlin College, Oberlin, OH
1998-2010 CEO, Midwest Neuroscience Inc.
1998-2001 Adjunct Associate Professor of Psychology, Bowling Green State University, Bowling Green, OH
1998-2005 President, Curtis Research Institute (501c3)
1998-01 Medical Director, Mercy Epilepsy Institute, Toledo, OH
1996-98 Associate Professor, Department of Neurology, Medical College of Ohio, Toledo, OH
1996-98 Director, Comprehensive Epilepsy Center, Medical College of Ohio, Toledo, OH
1996-98 Medical Director, Neurodiagnostic Services, Medical College of Ohio, Toledo, OH
1994-96 Assistant Professor, The Ohio State University Medical School, Columbus, OH
1993-96 Clinical Associate, Department of Neurology, The Cleveland Clinic Foundation, Cleveland, OH
1992-93 Assistant Professor of Neurology, Medical College of Pennsylvania, Philadelphia, PA
1992-93 Medical Director, Mid-Atlantic Regional Epilepsy Center, and EEG Laboratory, Philadelphia, PA
1990-92 Post-Doctoral Research Fellow, University of Pennsylvania, Philadelphia, PA
1989-90 Senior Resident Associate, Mayo Clinic, Rochester, MN
1980-82 Graduate Teaching Assistant, Department of Biology, University of Houston, Houston, TX
1980 Graduate Teaching Assistant, Department of Biology, Eastern Michigan University, Ypsilanti, MI
Awards and Honors:
2022 Outstanding Leadership Award for “Innovation in Technology” as the CEO of Sativa Science,
Internet 2.0 Conference
2010 Western Division Nastar Giant Slalom Nationals Qualifier, 52 year-old age group.
2007 Western Division Nastar Giant Slalom Regional Qualifier, 49 year-old age group.
2000 Six-time Smitty Stevens Annual Memorial Nastar, Race Winner, Winter Conference on Brain Research.
1993 Clinical Investigator Development Award, National Institutes of Health
1993 Doris Flynn Fellowship, The Cleveland Clinic Foundation
1992 Grass Foundation Neurophysiology Fellowship, The University of Pennsylvania
1990 Dana Neuroscience Fellowship, The University of Pennsylvania
1988 Neurology Residents’ Epilepsy Research Competition Award, Abbott Pharmaceuticals, “The Role of Adenosine in Epilepsy”.
1986 G. Milton Shy Award from the American Academy of Neurology for essay on Creutzfeldt-Jakob Disease. The highest neurology award in North America given to a medical student
1986 National Dean’s List, Wayne State University Medical School.
1985 National Dean’s List, Wayne State University Medical School
1972 Midwest American Champion, professional sled racing, 5-dog class
1973 Midwest American Champion, professional sled dog racing, 7-dog class
1973 Third place in the Can-Am championship race
1974 Midwest American Champion, professional sled dog racing, 7-dog class.
1974 Second place in the Can-Am championship race.
Grants and Research Support:
2012 P.I. :UCB SP 0980; A Prospective, Multinational, Open-Label, Single Arm, Explorative Study to Evaluate the Tolerability and Efficacy of Lacosamide when Added to Levetiracetam with Withdrawal of the Concomitant Sodium Channel Blocking Antiepileptic Drug in Subjects with Uncontrolled Partial-Onset Seizures.
2011 NIH R25DA033032; Big Sky Brain project, K-12 educational grant; co-investigator, Missoula, MT.
2010 P.I. Supernus 801P301: Multicenter, Double-Blind, Randomized, Placebo-Controlled, Three-Arm, Parallel Group Study to Evaluate the Efficacy and Safety of Oxcarbazepine Extended-Release as adjunctive Therapy in Subjects with Refractory Partial Seizures due to Epilepsy
2010 P.I. Supernus 801P302: Multicenter, Open-Label Extension Study to Evaluate the Long- Term Safety and Tolerability of Oxcarbazepine Extended-Release as Adjunctive Therapy in Subjects with Refractory Partial Epilepsy.
2000-04 Curtis Research Institute, principal investigator, $30,000 direct costs, adeno-associated virus vector transduction in rat brain .
1996-99 NIH RO1 #NS33539, co-investigator, $66,321.00 total costs, Human A1-Adenosine Receptor Action in Brain.
1994-99 NIH #K08NS01705-01A1, principal investigator, $414,450.00 total costs, The Role of Adenosine in Epilepsy
1996-97 Abbott Laboratories, principal investigator, $43,920.00 direct costs, Safety and Efficacy of tiagabine HCL as Adjunctive Treatment
1997-98 Abbott Laboratories, principal investigator, $35,880.00 direct costs, Safety and Efficacy of tiagabine HCL as Adjunctive Treatment-open label extension
1997-98 Glaxo-Welcome, co-investigator, $26,698.00 direct costs, Lamotrogine or Valproate/Carbamazepine withdrawing to monotherapy
1992-93 Grass Foundation Neurophysiology Fellowship, $30,000.00 total costs
1990-92 Epilepsy Foundation of America, Research Grant, $25,000.00 total costs, The Role of Adenosine in Brain Function
1990-92 Charles Dana Neuroscience Fellowship, $80,000.00 total costs, sponsored by Marc Dichter, MD, PhD, through the David Mahoney Institute of Neuroscience, University of Pennsylvania, Philadelphia, PA
Invited Lectures (Partial List)
Current Trends in Clinical Cannabinoid Molecule Development, chairman of a short course presented at the Winter Conference on Brain Research, Breckenridge, CO, January 2024
Use of Cannabinoids in Neurologic Disease, presented to Department of Neurology Grand Rounds, Wayne State University, Detroit, MI. 10-4-19
Epilepsy in the Wild West; Presented to Cambridge University Department of Neurology Faculty, London, England, July 19, 2016
“Recent Advances in Epilepsy” presented at the University of Montana Recent Advances in Clinical Medicine” symposium 2012
University of Washington, Update on the Northwest Consortium of Epilepsy Centers; at “The Northwest Regional Approach to Epilepsy Management” conference, September 14, 2012.
Fundamentals of Critical Care: Neurological Support; Community Medical Center 5-31-12
Neuromonitoring in Critical Care; April, 2012; Community Medical Center
Blast Brain Injury in Deployed Soldiers: “From Battlefield to Bench”; March, 2012; Missoula Montana Public Lecture
Montana Neuroscience Foundation invited public lecture; 10-14-09; “Epilepsy Diagnosis, Treatments, and New Research”
Saint Patrick Hospital Grand Rounds, 4-20-09 “Treatment of TIA and Stroke”.
Michigan State University, Department of Neurology Grand Rounds, 11/02; Epilepsy, Diagnosis and Treatment
Neurobiology Seminar Series, Department of Anatomy and Physiology, Medical College of Ohio, What’s new with adenosine A1 receptors, September 1996.
Faculty, Comprehensive Clinical Neurophysiology Annual Course, Cleveland Clinic, 1995, 1996, 1997, 1998, 1999 Synaptic Transmission & Physiologic Basis of the EEG.
Seventh Annual Cleveland Clinic-Bethel Epilepsy Symposium, 1996: “Etiologies of the Epilepsies”
Bibliography:
Original Papers:
Barraco, R. A., T. H. Swanson, J.W. Phillis, and R. E. Berman. 1984. Anticonvulsant effects of adenosine analogues on amygdaloid-kindled seizures in rats. Neurosci. Lett. 46:317-322. 2 Phillis, J.W., T. H. Swanson and R. A. Barraco. 1984. Interactions between nifedipine and adenosine in the rat cerebral cortex. Neurochem. Int. 6:693-699.
3 Swanson, T. H. and C. L. Green. 1986. Nifedipine: more than a calcium channel blocker. Gen Pharmac. 17(3):255-260.
Swanson, T. H., P. L. Zinkel and P. L. Peterson. 1987. Bilateral anterior cerebral artery occlusion in an alcohol abuser with sickle-cell trait. Henry Ford Hosp. Med. J . 35(1):67-70.
Swanson, T. H. 1987. The clinician’s guide to Creutzfeldt-Jakob disease, Henry Ford Hosp. Med. J. 35(1):76-83.
Swanson, T. H. and J. W. Phillis. 1987. Progesterone in seizure therapy, Neurology. 37:1433.
Swanson, T. H. and J. W. Phillis. 1988. Effects of the muscurinic antagonists pirenzipine and gallamine on spontaneous and evoked responses of rat cerebral cortical neurons. Br. J. Pharmac. 94:192-198.
Cascino, G. D., B. Westmoreland, T. H. Swanson and F. W. Sharbrough. 1991. Seizure-associated speech arrest in elderly patients. Mayo Clinic Pro. 66:254-258.
Swanson, T. H., P. J. B. Garrett, L. J. Burdette, G. D. Cascino and F. W. Sharbrough. 1991. Outcome of patients with early seizures following anterior temporal lobectomy. J. Epilepsy . 4:199-203.
Swanson, T. H. 1995. The pathophysiology of human mesial temporal lobe epilepsy. J. Clin. Neurophys. 12(1):2-22.
Swanson, T. H., J. Drazba and S. A. Rivkees. 1995. Adenosine A1 receptors are located predominately on axons in the rat hippocampal formation. J. Comp. Neurol . 363:517-531.
Draughn, L. R. and T. H. Swanson. 1997. Axillary Somatosensory Evoked Potential Response: An Alternate Peripheral Recording Site. J. Clin. Neurophys . 15(1):64-68.
Swanson, T. H., S. E. Krahl, Y. Z. Liu and S. A. Rivkees. 1998. Evidence for physiologically active axonal adenosine receptors in the rat corpus callosum. Brain Res. 784:188-198.
Swanson, T. H., M. J. O’Connor and M. R. Sperling. 1998. Strong paired pulse depression of dentate granule cells in slices form patients with temporal lobe epilepsy, J. Neural. Transm. 105:613-625.
Rivkees, S.A., A. P. Ijzerman, and T. H. Swanson. 1998. New insights into the molecular mechanisms of A1 adenosine receptor action. Drug Development Research. 45:93-102.
Book Chapters
Swanson, T. H. and M. R. Sperling. 1994. “Seizures That Do Not Look Like Seizures.” In Imitators of Epilepsy. edited by Fisher. New York: Demos. 11-26.
Swanson, T. H. 1997. “The Electrophysiology of Human Epileptic Hippocampus and Temporal Cortex.” In The Treatment of Epilepsy: Principles and Practice . edited by E. Wyllie. Philadelphia: Lea and Febiger. 2nd Edition.
Jones, S. W. and T. H. Swanson. 1997. “Basic Cellular Neurophysiology.” In The Treatment of Epilepsy: Principles and Practice. edited by E. Wyllie. Philadelphia: Lea and Febiger. 2nd Edition.
Timofeeva, O. A. and T. H. Swanson. 1998. “Neurophysiology of Epileptic Seizures: Animal Experience.” In Epileptic Seizures. edited by Hans Lüders. New York :John Whiley and Sons.
Swanson, T. H. and S. A. Rivkees. 1998. “Immunochemical Analysis of Neurotransmitter Receptors.” In Receptor Localization: Laboratory Methods and Procedures . edited by M. Ariano. N.p.:John Whiley.
Swanson, T. H. 1998. “Synaptic Transmission.” In Comprehensive Clinical Neurophysiology,. edited by Levin and Lüders. N.p.:Wiley-Liss, Inc.
Swanson, T. H. 1998. “The Physiologic Basis of the EEG.” In Comprehensive Clinical Neurophysiology. edited by Levin and Lüders. N.p.:W. B. Saunders.
Swanson, T.H. 2002. “The Origins of the Signals”. In Fundamental of EEG Technology, 2/e. edited by Burgess, Klem, and Luders.N.p: Lippincott Williams & Wilkin
Abstracts
Swanson, T. H., C. L. Green and M. A. Morón. “Regional distribution of adenosine deaminase activity in rat brain” absttract inThe Physiologist , (1985):28(4):329.
Fredholm, B. B., P. S. Hu, E. Lindgren, M. Duner-Engstrom and T. H. Swanson. “Interactions between calcium-channel agonists and antagonists at the pre-junctional adenosine receptor.” absrac in Ann. New York Acad. Sci. (1988):522.
Swanson, T. H., K. A. Hirschorn, G. D. Cascino and F. W. Sharbrough. “Outcome of patients with early seizures following epilepsy surgery.” absract in Epilepsia , (1989):30:728.
Cascino, G. D., B. Westmoreland, T. H. Swanson and F. W. Sharbrough. “Speech arrest with EEG correlates “transient ictal attacks.” (presented at the American Academy of Neurology annual meeting, Miami, 1990.)
Swanson, T. H. and L. M. Masukawa. “N6-Cyclopentyladenosine, a stable adenosine analog, exerts concentration-dependent effects on evoked granule cell activity.” abstract in Soc. Neurosci. Abstr . (1991):17(2):1548.
Swanson, T. H. Adenosine increases the signal to noise ratio in fascia dentata by a pre-synaptic mechanism, abstract in Soc. Neurosci. Abstr .
Swanson, T. H. and L. M. Masukawa. “Carbamazepine blocks adenosinergic excitaion in the hippocampus” abstract in Epilepsia (1991):32(3):35
Swanson, T. H. “The effects of A-1 specific adenosine analogs on synaptic transmission in the human hippocampal slice.” absract in Int. J. Purine and Pyrmid. Res. (1992):32(1):43.
Swanson, T. H., M. R. Sperling, M. J. O’Connor and H. O. Lüders. “Electrophysiologic evidence for increased feedback and decreased feedforward inhibition in human epileptic dentate gyrus.” absract in Epilepsia (1995).
Swanson, T. H., W. C. Zhen, S. A. Rivkees and J. Drazba. “Immunocytochemical localization of hippocampal adenosine A1 receptors to axons but not dendrites or cell bodies.” absract in Society for Neuroscience Abstracts. (1995).
Krahl, S. E., Y. Z. Liu and T. H. Swanson. “Evidence for Physiologically active Axonal A1 Adenosine Receptors.” (presented at the Society for Neuroscience annual meeting, 1996.)
Draughn, L. R., and T. H. Swanson. “Axillary SSEP Response: An Alternate Peripheral Recording Site.” abstract in American Society for Neurophysiological Monitoring , (Spring, 1997).
Swanson, T. H., S. E. Krahl, S. A. Rivkees and O. A. Timofeeva. “Rat brain adenosine A1 receptor antisense decreases specific adenosine ligand binding.” (presented at the Society for Neuroscience annual meeting, 1997.)
Daube, J. R., M. A. Aminoff, P. Antuono, R. Brey, R. K. Deuel, J. Emnett, W. J. Koroshetz, T. H. Swanson, J. W. Phillis and S. D. Yankton. “The Importance of Animal Research in Neuroscience Advances: A Historical Perspective.” (presented at the American Academy of Neurology annual meeting, 1998.)